This Sources Sought opportunity from Department Of State was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Molecular Diagnostic Laboratory Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The U.S. Department of State, through the Bureau of Global Health Security and Diplomacy, is pursuing an all-inclusive molecular diagnostic laboratory services contract under solicitation STATE-MDLS-2026 to support global health security initiatives across Sub-Saharan Africa and potentially other nations as part of the America First Global Health Security strategy. This acquisition is structured as a lowest price technically acceptable (LPTA) award, requiring vendors to meet six mandatory eligibility criteria before price becomes the determining factor: possession of a Stringent Regulatory Authority approval for instruments and assays, use of a closed-system diagnostic platform, demonstrated in-country operational presence in Sub-Saharan Africa, instrument-level data connectivity to government systems, broad availability of both instruments and assays, and regulatory registration or expedited pathways in each contracted country. The contract envisions an annual spend between $120 million and $220 million, with pricing based on volume-based per-test bands covering global goods and country-specific services including logistics, maintenance, and supply chain management. Performance is measured through strict key performance indicators such as 95% instrument uptime, zero temperature excursions in cold chain shipments, delivery of reagents with at least 70% of shelf life remaining, and mean time to repair not exceeding 72 hours. The contractor must maintain forward stock of spare parts and field-replaceable units at regional hubs, ensure continuous electronic temperature monitoring compliant with IATA DGR standards, and provide real-time data uploads to a government supply visibility dashboard. Delivery and service performance occur at designated laboratory sites across contracted countries, with the contractor managing end-to-end logistics from manufacturing to last-mile distribution under DDP-like terms. All operations must adhere to ISO 15189:2022 for quality management, NIST SP 800-52 Rev. 2 for encrypted data transmission (minimum TLS 1.2), and FedRAMP Moderate for cloud-based systems. The contractor is required to submit detailed annual and quarterly reports including KPI performance, supply chain status, surge readiness exercises, and country-specific activation plans—all subject to approval by the Contracting Officer’s Representative. Key personnel must remain continuously staffed, and subcontractors are permitted only for logistics or field support with full prime accountability retained. Any stockout, instrument outage exceeding 48 hours, connectivity loss, or cold chain breach triggers mandatory immediate reporting to the government. The contract includes provisions for termination for convenience or default with full transition obligations to ensure uninterrupted diagnostic services, and requires strict adherence to
General Info
Agency
NAICS
Place of Performance
Washington, DC, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The U.S. Department of State, Bureau of Global Health Security and Diplomacy (GHSD), is issuing this Request for Information (RFI) in conjunction with the attached DRAFT Performance Work Statement (PWS) for the All-Inclusive Molecular Diagnostic Laboratory Services procurement. The new activity, if awarded, will cover molecular diagnostic laboratory testing and services across Sub-Saharan African and potentially other countries as part of the America First Global Health Security (AFGHS) strategy.
Responses to the questions below are requested, but entirely optional, from qualified and eligible manufacturers of molecular diagnostic platforms. Please see the attached DRAFT PWS for eligibility criteria. Responses will be used to inform the final PWS and will not be used for source selection purposes.
Where a question asks about specific contracted countries, please address each country individually rather than providing a general response. Where a question asks about current operational data or performance metrics, please provide actual data where available rather than estimates.
Respondents are encouraged to answer each question as succinctly as possible (800-character count/question, including spaces). If responding to each question is not feasible, qualified and eligible manufacturers may submit responses to a select number of questions or decide not to respond at all. Not responding to this RFI or providing only limited responses bears no consequence to the outcome of the eventual competition, if any solicitation will be released.
Responses are to be submitted via this link: https://forms.cloud.microsoft/g/smW7MpdKHN.
Responses should be submitted no later than Wednesday, June 17th, 5:00PM EST. No email responses are accepted; all responses should be submitted through the link provided above.
This RFI does not constitute a solicitation and does not obligate the Government to issue a solicitation or make an award. No reimbursement will be made for any costs incurred in responding to this RFI.
More opportunities from Department Of State → Acquisitions - Aqm Momentum
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
